immunity
发表于 2025-3-25 04:21:46
Aboobucker Ilmudeen,Anand Nayyarr patients over the age of 70 and increasing data suggests that chronologic age may be an insufficient predictor of patient outcomes. In this chapter, we discuss the challenges of making therapeutic decisions in older patients with brain tumors, the potential role of geriatric assessment and key cli
统治人类
发表于 2025-3-25 09:46:27
http://reply.papertrans.cn/20/1903/190248/190248_22.png
想象
发表于 2025-3-25 13:12:03
Oligodendrogliomas define by maximal safe surgical resection followed by radiation and chemotherapy. Due to the chemosensitivity of these tumors, there may be safe approaches to defer radiotherapy. In this chapter, we discuss the evidence that guides decision-making for clinicians. Prognosis for these tumors is measured in years and decades.
gnarled
发表于 2025-3-25 18:18:20
http://reply.papertrans.cn/20/1903/190248/190248_24.png
修改
发表于 2025-3-25 22:55:39
http://reply.papertrans.cn/20/1903/190248/190248_25.png
Carcinogenesis
发表于 2025-3-26 03:51:40
Treatment of Ependymoman and chemotherapy depends on age, tumor location, extent of resection and tumor grade. In this chapter, we provide an overview of the clinical features of ependymoma, evidence based treatment strategies and practical considerations.
Excitotoxin
发表于 2025-3-26 06:58:55
Brain Edema and Corticosteroid Toxicitye effects. It is important that steroids are used only for the purpose of symptomatic benefit and not to address neuroimaging evidence of edema. In this chapter, we provide guidance on optimal use, dosing and tapering of corticosteroids, describe key toxicities and suggest measures to prevent and counteract side effects.
Debark
发表于 2025-3-26 10:52:24
http://reply.papertrans.cn/20/1903/190248/190248_28.png
Guaff豪情痛饮
发表于 2025-3-26 16:02:24
http://reply.papertrans.cn/20/1903/190248/190248_29.png
anarchist
发表于 2025-3-26 19:33:38
Management of Neurocognitive Symptomsognitive syndromes and provide a framework for localization, evaluation and management. As many cognitive symptoms are multifactorial in etiology, treatment approaches combine several non-pharmacologic strategies to address sleep, mood and stress in conjunction with pharmacologic approaches.